Group 1 - The core viewpoint of the articles highlights Hong Kong's efforts to establish a robust framework for Traditional Chinese Medicine (TCM) to enhance its global presence and acceptance [1][2][3] Group 2 - Hong Kong has developed a regulatory system for TCM, including the establishment of the Hong Kong Chinese Medicine Standards and a Chinese Medicine Testing Center, which will begin phased operations in December 2025 [1] - The Hong Kong government has invested a total of 1 billion HKD in the Chinese Medicine Development Fund since 2019, supporting over 10 funding programs in training, research, public awareness, industry development, and quality enhancement [2] - As of November 2025, there are 10,842 registered Chinese medicine practitioners in Hong Kong, with over 90% practicing in the community, creating a strong grassroots healthcare network [2] Group 3 - The Hong Kong Chinese Medicine Hospital, set to begin phased services in December 2025, aims to promote TCM education, training, and research innovation, supporting clinical research and the development of Chinese patent medicines [2] - The TCM industry in Hong Kong actively organizes promotional activities, with government support for projects that enhance public understanding and recognition of TCM [2][3]

Core Insights - Traditional Chinese medicine (TCM) is poised for historic global development opportunities by 2025, supported by the World Health Organization's push for traditional medicine integration into public health systems and legislative efforts in regions like the EU and ASEAN to expand market access for TCM [1] - The documentary series "Four Seas TCM" premiered on November 1, 2025, generating significant international interest and interaction, with over 2.6 billion online engagements, setting a new benchmark for the international dissemination of TCM culture [3][7] Group 1: Global Expansion of TCM - TCM is being standardized and internationalized, with new TCM centers established in countries along the Belt and Road Initiative, and successful completion of Phase III clinical trials for herbal products like Dan Shen Pian in the U.S. [1] - The documentary "Four Seas TCM" features a three-pronged approach of documentary, new media dissemination, and international events, showcasing TCM's cultural integration across various regions including Asia, Europe, and the Americas [3][4] Group 2: Audience Engagement and Cultural Dialogue - The Z generation has emerged as a core audience for TCM, with nearly 90% of engaged users being from the Z and Y generations, and over 80% holding university degrees, indicating a strong recognition of TCM culture among young, educated demographics [7] - The documentary emphasizes a narrative that fosters cross-cultural dialogue, focusing on the holistic approach of TCM rather than merely its technical aspects, allowing diverse audiences to find resonance with TCM practices [4][9] Group 3: Educational and Practical Impact - The documentary has been integrated into international exchange curricula at institutions like Beijing University of Chinese Medicine and Hong Kong Baptist University, highlighting its role as an educational resource for TCM [11] - The trade value of Chinese herbal products is projected to reach $8.38 billion in 2024, with service trade becoming a new growth engine, as evidenced by the establishment of international companies and overseas cultivation bases for TCM products [13] Group 4: Future Directions and Innovations - The documentary explores the intersection of TCM with modern technology, particularly in regions like Silicon Valley, where practitioners with strong tech backgrounds are investigating TCM's principles through contemporary scientific methods [14][15] - The dynamic adaptation of TCM to local contexts is illustrated through examples from Indonesia, where local herbs are integrated into TCM practices, showcasing TCM's evolving nature as a living system [17]

Core Viewpoint - The establishment of the "Belt and Road" Traditional Chinese Medicine (TCM) Technology Achievement Transformation Joint Body in Sichuan is expected to enhance cross-border collaboration and internationalization of TCM, addressing existing challenges in the sector [1][2]. Group 1: Establishment of the Joint Body - The joint body was initiated by 11 organizations, including the Sichuan Academy of Traditional Chinese Medicine and Chengdu University of Traditional Chinese Medicine, aiming to cover the entire chain of "government, industry, academia, research, finance, and application" [1][2]. - The joint body will serve as a "collaboration hub" for TCM internationalization, facilitating efficient connections between policies, technology, capital, and markets [2]. Group 2: Challenges and Opportunities - Current challenges for TCM in the "Belt and Road" initiative include ineffective cross-border collaboration mechanisms, difficulties in standard alignment, and uncoordinated intellectual property protection systems [1]. - The joint body signifies a shift from "dispersed promotion" to "systematic collaboration" in the international transformation of TCM [2]. Group 3: Future Plans - The next steps for the joint body include building a cross-border achievement docking network and promoting the standardization and scaling of TCM products and services internationally [2]. - The joint body will also focus on international joint research and talent cultivation, aiming to deeply integrate TCM research with international market demands [2].

Core Viewpoint - The establishment of the Gansu Traditional Chinese Medicine Industry Association marks a new collaboration platform between the government and the market to promote the development of the traditional Chinese medicine industry in Gansu Province, which has surpassed a scale of 100 billion yuan [1][3]. Group 1: Industry Development - Gansu Province is recognized as a significant birthplace of traditional Chinese medicine and a major production area for authentic medicinal materials [3]. - The association aims to focus on "serving the industry, empowering members, inheriting innovation, and going international" to promote the integration of the entire traditional Chinese medicine industry chain [3][4]. - Gansu has been designated as a national pilot province for comprehensive reform and development of traditional Chinese medicine, with the industry becoming a key area for the province's economic and social development [3]. Group 2: Association Objectives - The newly established association will work on building an international cooperation system for the traditional Chinese medicine industry, leveraging resources from Hong Kong and Macau to transform resource advantages into industrial advantages [4]. - It will promote digitalization and standardization, establish a traceability and quality evaluation system for medicinal materials, and enhance industry self-discipline and integrity [4]. - The association plans to integrate traditional Chinese medicine with culture, tourism, and health industries to enhance brand influence and tell the story of "Long Medicine" [4].

Core Viewpoint - The documentary "The Amazing Traditional Chinese Medicine Overseas: Europe" highlights the growing acceptance and integration of Traditional Chinese Medicine (TCM) in various European countries, showcasing its effectiveness and the cultural exchange involved in its practice [1][11]. Group 1: Effectiveness and Acceptance - In Germany, Dr. Kander has integrated TCM into his practice, receiving five-star reviews for his clinic, where he uses herbal medicine and acupuncture to help patients with infertility, demonstrating the effectiveness of TCM [3]. - In the UK, Dr. Shulan has built a reputation over 30 years, successfully treating patients with severe eczema and infertility, and has trained over 2,000 local practitioners, indicating a deepening trust in TCM [5]. - The UK Acupuncture Council's members acknowledge that while acupuncture is easily accepted, the theoretical aspects of herbal medicine require time to build trust through demonstrated efficacy [5]. Group 2: Localization and Education - Dr. Huang in Lisbon adapts TCM teachings for a diverse classroom of students from 15 countries, using relatable language to make complex concepts accessible, which aids in the understanding and acceptance of TCM [7]. - Dr. Shubai in Paris combines TCM with Western medicine, emphasizing a human-centered approach that addresses both physical and psychological aspects of health, further integrating TCM into local practices [9]. - Nanjing University of Chinese Medicine has trained nearly 10,000 overseas TCM professionals since the mid-20th century, showcasing the institution's role in promoting TCM internationally [10]. Group 3: Cultural Exchange and Global Reach - TCM has been recognized in 196 countries, with 113 WHO member states acknowledging acupuncture, reflecting its global acceptance and the sharing of health solutions [9]. - The documentary emphasizes that TCM's journey abroad is not just about medical practice but also about fostering cultural dialogue and understanding, as it addresses health needs across different societies [11].

Core Viewpoint - The article highlights the successful hosting of the sixth "International Advanced Training Course on Clinical Practice and Research Progress of Traditional Chinese Medicine" in Serbia, marking a significant step in the internationalization and collaboration of TCM [4][7]. Group 1: Event Overview - The training course took place from December 6 to 18 in Belgrade, Serbia, led by the China Academy of Chinese Medical Sciences, attracting nearly 200 participants from 25 countries, including Serbia, Slovakia, and Poland [4]. - The project has evolved from a one-way knowledge transfer to a deep collaboration model, reflecting a significant shift in the internationalization of TCM [6][8]. Group 2: Historical Context and Development - The project began 8 years ago with the first training course held in Beijing, which has since grown to include over 200 medical personnel from more than 20 countries [5]. - The initiative aligns with China's "14th Five-Year Plan" and various policies aimed at integrating TCM into the Belt and Road Initiative, providing strong support for TCM's international outreach [5][6]. Group 3: Collaborative Achievements - The project has established a collaborative network with over 30 universities and institutions across more than 10 countries, facilitating the publication of 31 articles on TCM's international development [6]. - Notably, a Brazilian participant successfully advocated for the approval of the country's first acupuncture undergraduate program, showcasing the project's impact on local medical education [6]. Group 4: Future Prospects - During the event, Serbia announced plans to establish a National Integrative Medicine Center at the University of Belgrade by 2026 and is exploring the creation of a joint laboratory with China [7]. - The discussions during the seminar focused on integrating TCM into local medical practices, emphasizing a collaborative approach to addressing common health issues [7][8].

Overview - The core viewpoint of the article highlights the growing demand for Xuan Shen (玄参), a key traditional Chinese medicine, driven by the promotion of TCM clinical applications and supportive policies, with a projected demand of 415.91 tons and a market size of 249 million yuan in 2024 [1][10]. Market Policies - The Chinese government has issued multiple policies to enhance the development of the TCM industry, focusing on improving the standards for planting and processing Chinese medicinal materials, including Xuan Shen [5][6]. Industry Chain - The Xuan Shen industry chain includes upstream activities such as seed selection, seedling cultivation, and planting, while the midstream involves processing, including initial and deep processing. The downstream market encompasses pharmaceuticals, health products, functional foods, and wellness beverages [6][8]. Current Development - The demand for Xuan Shen is steadily increasing due to the rising awareness of health management and chronic disease care among the public, leading to its application in health products and functional foods [1][10]. Competitive Landscape - The Xuan Shen industry features numerous participants, including both planting and processing enterprises. Key players like Kangmei Pharmaceutical and Hu Qing Yu Tang dominate the high-end market through standardized processing and brand recognition [11][12]. Future Trends - The Xuan Shen industry is expected to focus on enhancing the quality of medicinal materials, with an emphasis on breeding high-yield and resilient varieties, and promoting eco-friendly cultivation methods. Additionally, there is potential for expanding into international markets, particularly in Southeast Asia and Western countries [13][14].

Core Viewpoint - Gansu Longshen Rongfa Pharmaceutical Co., Ltd. has received official certification for its health product "Huangqi Danggui Capsules" from the Macao Special Administrative Region, allowing it to enter the Macao market without prior drug import permits, marking a significant milestone in the company's expansion into the Guangdong-Hong Kong-Macao Greater Bay Area and international markets [1][2]. Group 1 - The "Huangqi Danggui Capsules" are made from traditional medicinal materials Huangqi and Danggui, combined with microcrystalline cellulose and silicon dioxide, adhering to traditional Chinese medicine principles and modern formulation techniques, and have been scientifically validated for their protective functions against radiation hazards [1]. - The "Macao Non-Drug Certification" system is a unique regulatory framework established by the Macao government for high-value functional foods and health products, providing a clear pathway for quality health products and facilitating access to markets in Portuguese-speaking countries, the EU, Latin America, and the Middle East [2]. - The recognition of "Huangqi Danggui Capsules" not only serves as an authoritative endorsement of its quality, safety, and efficacy by the Macao government but also signifies a critical step in the company's strategy to internationalize traditional Chinese medicine health products [2]. Group 2 - In recent years, the company has actively expanded its international presence through its wholly-owned subsidiary, Gansu New Silk Road Industrial Investment Co., Ltd., targeting markets in East Asia, Central Asia, Southeast Asia, and Europe, with successful product registration and export sales in Russia, Kyrgyzstan, Singapore, and Thailand [2]. - The company plans to leverage its full industry chain advantages in traditional Chinese medicine cultivation, deep processing, research, and production to enhance product quality and technological innovation, while actively researching and aligning with health product regulations in different countries and regions [3]. - The company aims to provide high-quality health solutions derived from China to global consumers, contributing to the "Healthy China" initiative and the internationalization of traditional Chinese medicine [3].

Core Viewpoint - The article discusses the establishment of the overseas "Qihuang Academy" by Weifang Nursing Vocational College, aimed at promoting the internationalization of traditional Chinese medicine (TCM) and responding to the national strategy of "Vocational Education Going Global" [1][4]. Group 1: Foundation Building - The college strengthens its institutional framework by integrating resources and establishing a collaborative mechanism with over 20 local institutions that have TCM-related programs, forming the Shandong TCM Going Global University Alliance [1]. - The alliance initiates a "virtual teaching and research room" to conduct collaborative research and training in TCM, focusing on international development and regular academic seminars [1]. - A comprehensive "Overseas Qihuang Academy Construction Guide" has been developed, focusing on over 50 TCM techniques with high international acceptance, providing standardized teaching resources and quality assurance [1]. Group 2: Industry-Education Integration - The college adopts a "teaching follows production, school-enterprise collaboration" approach, embedding the overseas "Qihuang Academy" into the industry chain [2]. - In August 2025, the college will unveil the "Belarus-Qihuang Academy" in the China-Belarus Industrial Park, promoting a collaborative model that integrates education, research, clinical practice, industry, and culture [2]. - The college collaborates with Belarusian partners on clinical research in TCM rehabilitation and the localized cultivation of Chinese medicinal herbs, as well as the development of smart TCM diagnostic devices [2]. Group 3: Cultural Promotion - The college implements a comprehensive strategy to promote TCM culture, facilitating dialogue and mutual learning between TCM and local cultures [3]. - A cultural experience zone is established in overseas platforms, hosting events like "TCM Cultural Festivals" to engage local communities through interactive experiences [3]. - A bilingual curriculum and digital teaching resources are developed to ensure overseas students acquire practical skills while understanding the cultural wisdom of China [3]. Group 4: Future Directions - Weifang Nursing Vocational College aims to further expand the overseas "Qihuang Academy" to more countries, contributing to the internationalization of TCM and the global outreach of Chinese vocational education [4].

Core Insights - Pianzaihuang has been recognized as a "Chinese brand worth recommending to the world" at the 2025 China-France Brand Week in Paris, highlighting its efforts in promoting traditional Chinese medicine internationally [1] Group 1: Company Overview - Pianzaihuang Pharmaceutical Co., Ltd., established in 1999, focuses on pharmaceutical manufacturing, with products including liver disease medications, cold remedies, and dermatological treatments, while also expanding into daily chemicals and health foods [1] - The company has seen a year-on-year increase in sales of Pianzaihuang capsules, primarily among consumers under 40 years old [1] - Pianzaihuang is actively involved in the "Round Mountain Plan" in Zhangzhou, signing contracts with 240 renowned doctors and establishing four medical studios, serving 225,000 people [1] Group 2: Research and Development - A recent study by Professor Yu Jun's team at the Chinese University of Hong Kong has drawn attention to Pianzaihuang's role in preventing and treating non-alcoholic fatty liver disease [2] - The company has established an innovation research base in Daxing District, Beijing, planning to create a cultural and product display center that integrates product experience, cultural promotion, and traditional Chinese medicine consultations [2] Group 3: International Expansion - Pianzaihuang is actively exploring overseas markets, conducting market assessments in Brazil, Argentina, Singapore, and Malaysia to find quality partners for deep cooperation [3] - The company has obtained registration approvals for multiple traditional Chinese medicine products in countries like Laos and Mozambique, enhancing its international market access [2]